Viennese investigators examined the rate of progression to first-episode psychotic disorder in adolescents and young adults aged 13 to 25 years with subthreshold psychosis in this small randomized, double-blind, placebo-controlled trial. By study's end (12 months), 2 of 41 individuals (4.9%) in the omega-3 group and 11 of 40 (27.5%) in the placebo group had transitioned to psychotic disorder (P = .007).
http://archpsyc.ama-assn.org/cgi/content/abstract/67/2/146 Posted via email from nocx
No comments:
Post a Comment